<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
13.05.2019 08:30:00

Abiomed and Intersect ENT Stumble to Start 2019

Med-tech stocks like Abiomed (NASDAQ: ABMD) and Intersect ENT (NASDAQ: XENT) have been red hot in recent years. However, both of these businesses recently failed to live up to investors' expectations.In this episode of The Motley Fool's Industry Focus: Healthcare, host Shannon Jones and Fool.com contributor Brian Feroldi discuss what went wrong for both of these companies and whether the businesses can recover.To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. A full transcript follows the video.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu ABIOMED Inc.mehr Analysen

01.08.19 ABIOMED Neutral BTIG Research
02.11.18 ABIOMED Buy BTIG Research

Eintrag hinzufügen

Die neue Welt der Kryptoanlagen | BX Swiss TV

Aktien in diesem Artikel

ABIOMED Inc. 199.01 -43.62% ABIOMED Inc.
Intersect ENT Inc 21.11 -1.36% Intersect ENT Inc

Finanzen.net News

pagehit
FinanzenNet.Finando.Web.Core.Areas.Article.ViewModels.News.DetailsViewModel FinanzenNet.Finando.Web.Core.Extensions.VueComponent ;